Björn Tavelin

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

Annika Malmström, Bjørn Henning Grønberg, Christine Marosi et al. · The Lancet Oncology · 2012 · 1.2K citations

Neuro-oncology, Radiation Medicine, Radiation Therapy +8

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 840 citations

Surgical Oncology, Radiation Therapy, Medicine +8

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.

Barbro Linderholm, Björn Tavelin, Kjell Grankvist et al. · Journal of Clinical Oncology · 1998 · 270 citations

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

Barbro Linderholm, Kjell Grankvist, Nils Wilking et al. · Journal of Clinical Oncology · 2000 · 254 citations

Breast Cancer Survival Is Associated with Telomere Length in Peripheral Blood Cells

Ulrika Svenson, Katarina Nordfjäll, Birgitta Stegmayr et al. · Cancer Research · 2008 · 183 citations